Leveraging analytics to assure quality during the Covid-19 pandemic - The COVACTA clinical study example
The world has seen a shift in the ways of working during the Covid-19 pandemic. Routine activities performed at the clinical investigator sites (e.g. on-site audits) that are a part of Quality Assurance (QA) have not been feasible at this time. Analytics has played a huge role in contributing to our...
Main Authors: | Timothé Ménard, Rich Bowling, Pooja Mehta, Björn Koneswarakantha, Eileen Magruder |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Contemporary Clinical Trials Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451865420301460 |
Similar Items
-
‘Screening audit’ as a quality assurance tool in good clinical practice compliant research environments
by: Sinyoung Park, et al.
Published: (2018-04-01) -
Quality assurance guidance for scoring and reporting for pathologists and laboratories undertaking clinical trial work
by: Max Robinson, et al.
Published: (2019-04-01) -
Future vision for the quality assurance of oncology clinical trials
by: Thomas eFitzGerald, MD, et al.
Published: (2013-03-01) -
The Impact of Clinical Trial Quality Assurance on Outcome in Head and Neck Radiotherapy Treatment
by: Haoyu Zhong, et al.
Published: (2019-08-01) -
Data quality assurance and quality control measures in large multicenter stroke trials: the African-American Antiplatelet Stroke Prevention Study experience
by: Richardson DeJuran, et al.
Published: (2001-05-01)